Life Sciences
In 2018, the value of the global pharmaceutical market reached USD 1.2 trillion, with Turkey ranking at the 17th spot.
In 2018, the Turkish pharmaceuticals market grew in value by 26.1 percent, reaching TRY 30.94 billion.
Among the 11 raw material production facilities, 3 are owned by multinational companies.
Biotechnological products constituted 17.4 percent of prescription products with a value of TRY 6.1 billion across 28.8 million units in the past 12 months as of June 2019.
The reference biotechnological pharmaceutical market grew by 10.7 percent to a total of TRY 5.7 billion.
The biosimilar drug market grew by 54.2 percent to reach TRY 434.2 million.
Some key facts and figures in the Turkish medical devices sector include:
The Turkish medical devices market surpassed USD 2.0 billion in 2018.
İf You Chose to Work With Us;
Our Experience and Know - How Will Help You to Succeed in Discovering the Business Potential in Turkey.”
MAJOR PLAYERS
Comments
it was a very beneficial experience to us. Turkey’s location is so efficient. We had some concerns about the quality and timing but we didn’t face with any of them. Industry Istanbul was great on negotiation.
We have been doing business with Turkey with the connection of Industry Istanbul for 6 months. We are comfortable with their quality approach and time of delivery.
Industry Istanbul is a key solution partner for doing business in Turkey. While we can’t reach the manufacturer, they are always online and ready for the information.